Streetbeat News

Products Services

TRMB

Trimble has launched a new cloud-based version of its Log Inventory and Management System (LIMS) for forestry. The new Trimble LIMS PRO is aimed at small- and medium-sized companies, offering them the opportunity to realize productivity and growth gains.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 12:47 pm

CBAT

CBAK Energy Technology, Inc. (NASDAQ:CBAT) has announced strategic collaborations in Shangqiu City, China, to expand its battery production capacities. The collaborations involve investment and lease agreements that will allow CBAK Energy to meet the increasing demand for its 26700 cylindrical batteries at a lower cost. The company's subsidiary, Dalian CBAK, will pay an annual rental to use the Lessor's production line, which is expected to increase Dalian CBAK's capacity by approximately RMB300 million worth of batteries. The Lessor will cover the costs of renovating the production line, and production is expected to start this year.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 12:30 pm

WLDS

Wearable Devices Ltd. (NASDAQ:WLDS) has launched a licensing program for its Mudra gesture technology. The program allows original equipment manufacturers to customize the company's technology to meet their specific needs. The move is expected to significantly expand the company's addressable market by enabling businesses to develop their own co-branded touchless control products.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 12:19 pm

JAZZ

The European Medicines Agency's CHMP has recommended the approval of Jazz Pharmaceuticals' JZP458 for use as a component of a multi-agent chemotherapeutic regimen for acute lymphoblastic leukemia, lymphoblastic lymphoma.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 12:12 pm

WIMI

WiMi Hologram Cloud Inc. has developed a humanoid robot control system based on a head-mounted display (HMD) controlled by a brain-computer interface (BCI). The system allows interaction with the environment and humans, providing real-time feedback through the robot's embedded camera.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 12:10 pm

NVCR

Novocure has received a positive recommendation from an independent data monitoring committee to continue its Phase 3 PANOVA-3 trial. The trial is evaluating the effectiveness of Tumor Treating Fields Therapy in treating pancreatic cancer.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 12:02 pm

BGNE

BeiGene (NASDAQ:BGNE) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommending approval for tislelizumab as a treatment for advanced or metastatic esophageal squamous cell carcinoma (ESCC).

Portfolio Pulse from Charles Gross

July 21, 2023 | 11:58 am

META

Meta Platforms Inc's Instagram-linked app Threads is facing a user exodus, with daily active users dropping to 23.6 million from a peak of 49 million in July. The company is focusing on improving performance and introducing new features rather than increasing user engagement. Threads' relationship with Instagram initially boosted its popularity, but users were disappointed by the required Instagram account deletion to ditch Threads. Meta's shares are trading higher by 0.19% at $303.10 premarket on the last check Friday.

Portfolio Pulse from Anusuya Lahiri

July 21, 2023 | 11:58 am

MRK

Merck (NYSE:MRK) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for gefapixant, a non-narcotic oral selective P2X3 receptor antagonist developed for the treatment of adults with chronic cough. The recommendation will be reviewed by the European Commission for marketing authorization in the EU, with a final decision expected later this year.

Portfolio Pulse from Charles Gross

July 21, 2023 | 11:53 am

PFE

VGK

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Pfizer's Litfulo (Ritlecitinib) for the treatment of severe alopecia areata.

Portfolio Pulse from Charles Gross

July 21, 2023 | 11:52 am